Sexual Health Infolink (NSW Ministry of Health), 2019
As more services are beginning to provide hormonal therapies to trans and gender diverse people, the NSW Sexual Health Infolink (SHIL) has consolidated the key resources to guide best practice.
Bookmark SHIL’s Gender Affirming Care page for quick access to:
Clinical guidelines and patient fact sheets about hormonal therapies,
Specialist trans and gender diverse clinical services,
Counselling and peer support services,
Information and resources for family and friends.
The Sexual Health Infolink is a NSW Ministry of Health funded telephone and internet based information and referral service. It has been operating since 1989 and is staffed by specialist sexual health nurses.
APS (The Australian Psychological Society), September 2019
The Australian Psychological Society (APS) today released the following statement in support of transgender people in Australia, and challenging the unfounded claim that social media influences the gender of young people specifically:
“Empirical evidence consistently refutes claims that a child’s or adolescent’s gender can be ‘directed’ by peer group pressure or media influence, as a form of ‘social contagion’,” APS Fellow Professor Damien Riggs said.
Care providers need to be aware of the damage of inappropriate curiosity when working with people who are transgender, say Adam Shepherd, Benjamin Hanckel, and Andy Guise.
Encountering inappropriate curiosity is a common experience among people who identify as LGBT. This kind of behaviour shouldn’t happen in a healthcare facility, yet recent reports from Stonewall and the government’s Equalities Office confirm that this is a problem in healthcare and that it particularly affects people who are transgender.
What do we mean when we say that a healthcare provider is showing “inappropriate curiosity?” Researchers provided insight into what this is in a study where they describe trans participants being asked intrusive questions about their personal lives and being subjected to invasive physical examinations. Participants felt that these were irrelevant to why they had sought out medical care, and that their only purpose was to satisfy the personal interest of the healthcare practitioner. Imagine, for example, going to your GP for a chronic cough and being asked what genitals you have, or going for a foot X-ray and the radiographer making comments about your breasts.
Med J Aust. 2019 Aug 29. doi: 10.5694/mja2.50322. [Epub ahead of print]
To estimate rates of HIV infection, chlamydia, gonorrhoea, and infectious syphilis in transgender men and women in Australia; to compare these rates with those for cisgender people.
Cross‐sectional, comparative analysis of de‐identified health data.
We analysed data for 1260 transgender people (404 men, 492 women, 364 unrecorded gender), 78 108 cisgender gay and bisexual men, and 309 740 cisgender heterosexual people who attended 46 sexual health clinics across Australia during 2010–2017.
Main outcome measures
First‐visit test positivity for sexually transmitted infections (STIs), stratified by patient group and year; demographic and behavioural factors associated with having STIs.
14 of 233 transgender men (6.0%) and 34 of 326 transgender women (10%) tested during first clinic visits were chlamydia‐positive; nine transgender men (4%) and 28 transgender women (8.6%) were gonorrhoea‐positive. One of 210 tested transgender men (0.5%) and ten of 324 tested transgender women (3.1%) were diagnosed with infectious syphilis; 14 transgender men (3.5%) and 28 transgender women (5.7%) were HIV‐positive at their first visit. The only significant change in prevalence of an STI among transgender patients during the study period was the increased rate of gonorrhoea among transgender women (from 3.1% to 9.8%). Compared with cisgender gay and bisexual men, transgender men were less likely (adjusted odds ratio [aOR], 0.46; 95% CI, 0.29–0.71; P = 0.001) and transgender women as likely (aOR, 0.98; 95% CI, 0.73–1.32; P = 0.92) to be diagnosed with a bacterial STI; compared with heterosexual patients, transgender men were as likely (aOR, 0.72; 95% CI, 0.46–1.13; P = 0.16) and transgender women more likely (aOR, 1.56; 95% CI, 1.16–2.10; P = 0.003) to receive a first‐visit bacterial STI diagnosis.
The epidemiology of STIs in transgender people attending Australian sexual health clinics differs from that of cisgender patients. Gender details must be captured by health data systems to facilitate appropriate delivery of sexual health care.
Justice Connect have released a suite of free legal resources for young trans & gender diverse people and their families. These are available state by state to make it easier to understand the different legalities between each state and territory.